ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
4
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
4
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Apomorphine Hydrochloride Injection Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-21E8546
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Apomorphine Hydrochloride Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Apomorphine Hydrochloride Injection Market Insights, Forecast to 2030

Code: QYRE-Auto-21E8546
Report
December 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
EVER Pharma
Evolan Pharma AB (PharmSwed)

Apomorphine Hydrochloride Injection Market Size

The global Apomorphine Hydrochloride Injection market is projected to grow from US$ 260.2 million in 2024 to US$ 327.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.

Apomorphine Hydrochloride Injection Market

Apomorphine Hydrochloride Injection Market

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Covers:
This report presents an overview of global market for Apomorphine Hydrochloride Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Apomorphine Hydrochloride Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Apomorphine Hydrochloride Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Apomorphine Hydrochloride Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Apomorphine Hydrochloride Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Apomorphine Hydrochloride Injection sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Apomorphine Hydrochloride Injection Market Report

Report Metric Details
Report Name Apomorphine Hydrochloride Injection Market
Accounted market size in 2024 US$ 260.2 million
Forecasted market size in 2030 US$ 327.3 million
CAGR 3.9
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Parkinson Disease
  • Erectile Dysfunction
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ever Pharma, Evolan Pharma AB (PharmSwed)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Apomorphine Hydrochloride Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Apomorphine Hydrochloride Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apomorphine Hydrochloride Injection sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Apomorphine Hydrochloride Injection Market growing?

Ans: The Apomorphine Hydrochloride Injection Market witnessing a CAGR of 3.9 during the forecast period 2025-2030.

What is the Apomorphine Hydrochloride Injection Market size in 2030?

Ans: The Apomorphine Hydrochloride Injection Market size in 2030 will be US$ 327.3 million.

What is the Apomorphine Hydrochloride Injection Market share by application?

Ans: The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.

What is the Apomorphine Hydrochloride Injection Market share by region?

Ans: Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019.

Who are the main players in the Apomorphine Hydrochloride Injection Market report?

Ans: The main players in the Apomorphine Hydrochloride Injection Market are Ever Pharma, Evolan Pharma AB (PharmSwed)

What are the Application segmentation covered in the Apomorphine Hydrochloride Injection Market report?

Ans: The Applications covered in the Apomorphine Hydrochloride Injection Market report are Parkinson Disease, Erectile Dysfunction

What are the Type segmentation covered in the Apomorphine Hydrochloride Injection Market report?

Ans: The Types covered in the Apomorphine Hydrochloride Injection Market report are Pen Injectors, Infusion Pumps

Recommended Reports

Neurological Disorders

Hydrochloride APIs

Injectables & Analogs

1 Study Coverage
1.1 Apomorphine Hydrochloride Injection Product Introduction
1.2 Market by Type
1.2.1 Global Apomorphine Hydrochloride Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Pen Injectors
1.2.3 Infusion Pumps
1.3 Market by Application
1.3.1 Global Apomorphine Hydrochloride Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Apomorphine Hydrochloride Injection Sales Estimates and Forecasts 2019-2030
2.2 Global Apomorphine Hydrochloride Injection Revenue by Region
2.2.1 Global Apomorphine Hydrochloride Injection Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Apomorphine Hydrochloride Injection Revenue by Region (2019-2024)
2.2.3 Global Apomorphine Hydrochloride Injection Revenue by Region (2025-2030)
2.2.4 Global Apomorphine Hydrochloride Injection Revenue Market Share by Region (2019-2030)
2.3 Global Apomorphine Hydrochloride Injection Sales Estimates and Forecasts 2019-2030
2.4 Global Apomorphine Hydrochloride Injection Sales by Region
2.4.1 Global Apomorphine Hydrochloride Injection Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Apomorphine Hydrochloride Injection Sales by Region (2019-2024)
2.4.3 Global Apomorphine Hydrochloride Injection Sales by Region (2025-2030)
2.4.4 Global Apomorphine Hydrochloride Injection Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Apomorphine Hydrochloride Injection Sales by Manufacturers
3.1.1 Global Apomorphine Hydrochloride Injection Sales by Manufacturers (2019-2024)
3.1.2 Global Apomorphine Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Apomorphine Hydrochloride Injection in 2023
3.2 Global Apomorphine Hydrochloride Injection Revenue by Manufacturers
3.2.1 Global Apomorphine Hydrochloride Injection Revenue by Manufacturers (2019-2024)
3.2.2 Global Apomorphine Hydrochloride Injection Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Apomorphine Hydrochloride Injection Revenue in 2023
3.3 Global Key Players of Apomorphine Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Apomorphine Hydrochloride Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Apomorphine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Product Offered and Application
3.8 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Apomorphine Hydrochloride Injection Sales by Type
4.1.1 Global Apomorphine Hydrochloride Injection Historical Sales by Type (2019-2024)
4.1.2 Global Apomorphine Hydrochloride Injection Forecasted Sales by Type (2025-2030)
4.1.3 Global Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
4.2 Global Apomorphine Hydrochloride Injection Revenue by Type
4.2.1 Global Apomorphine Hydrochloride Injection Historical Revenue by Type (2019-2024)
4.2.2 Global Apomorphine Hydrochloride Injection Forecasted Revenue by Type (2025-2030)
4.2.3 Global Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
4.3 Global Apomorphine Hydrochloride Injection Price by Type
4.3.1 Global Apomorphine Hydrochloride Injection Price by Type (2019-2024)
4.3.2 Global Apomorphine Hydrochloride Injection Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Apomorphine Hydrochloride Injection Sales by Application
5.1.1 Global Apomorphine Hydrochloride Injection Historical Sales by Application (2019-2024)
5.1.2 Global Apomorphine Hydrochloride Injection Forecasted Sales by Application (2025-2030)
5.1.3 Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
5.2 Global Apomorphine Hydrochloride Injection Revenue by Application
5.2.1 Global Apomorphine Hydrochloride Injection Historical Revenue by Application (2019-2024)
5.2.2 Global Apomorphine Hydrochloride Injection Forecasted Revenue by Application (2025-2030)
5.2.3 Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
5.3 Global Apomorphine Hydrochloride Injection Price by Application
5.3.1 Global Apomorphine Hydrochloride Injection Price by Application (2019-2024)
5.3.2 Global Apomorphine Hydrochloride Injection Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Apomorphine Hydrochloride Injection Market Size by Type
6.1.1 US & Canada Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
6.1.2 US & Canada Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
6.2 US & Canada Apomorphine Hydrochloride Injection Market Size by Application
6.2.1 US & Canada Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
6.2.2 US & Canada Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
6.3 US & Canada Apomorphine Hydrochloride Injection Market Size by Country
6.3.1 US & Canada Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
6.3.3 US & Canada Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Apomorphine Hydrochloride Injection Market Size by Type
7.1.1 Europe Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
7.1.2 Europe Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
7.2 Europe Apomorphine Hydrochloride Injection Market Size by Application
7.2.1 Europe Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
7.2.2 Europe Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
7.3 Europe Apomorphine Hydrochloride Injection Market Size by Country
7.3.1 Europe Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
7.3.3 Europe Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Apomorphine Hydrochloride Injection Market Size
8.1.1 China Apomorphine Hydrochloride Injection Sales (2019-2030)
8.1.2 China Apomorphine Hydrochloride Injection Revenue (2019-2030)
8.2 China Apomorphine Hydrochloride Injection Market Size by Application
8.2.1 China Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
8.2.2 China Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Apomorphine Hydrochloride Injection Market Size by Type
9.1.1 Asia Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
9.1.2 Asia Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
9.2 Asia Apomorphine Hydrochloride Injection Market Size by Application
9.2.1 Asia Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
9.2.2 Asia Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
9.3 Asia Apomorphine Hydrochloride Injection Sales by Region
9.3.1 Asia Apomorphine Hydrochloride Injection Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Apomorphine Hydrochloride Injection Revenue by Region (2019-2030)
9.3.3 Asia Apomorphine Hydrochloride Injection Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Supernus Pharmaceuticals
11.1.1 Supernus Pharmaceuticals Company Information
11.1.2 Supernus Pharmaceuticals Overview
11.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Supernus Pharmaceuticals Recent Developments
11.2 Britannia Pharmaceuticals STADA
11.2.1 Britannia Pharmaceuticals STADA Company Information
11.2.2 Britannia Pharmaceuticals STADA Overview
11.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Britannia Pharmaceuticals STADA Recent Developments
11.3 Ever Pharma
11.3.1 Ever Pharma Company Information
11.3.2 Ever Pharma Overview
11.3.3 Ever Pharma Apomorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Ever Pharma Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ever Pharma Recent Developments
11.4 Evolan Pharma AB (PharmSwed)
11.4.1 Evolan Pharma AB (PharmSwed) Company Information
11.4.2 Evolan Pharma AB (PharmSwed) Overview
11.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Apomorphine Hydrochloride Injection Industry Chain Analysis
12.2 Apomorphine Hydrochloride Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Apomorphine Hydrochloride Injection Production Mode & Process
12.4 Apomorphine Hydrochloride Injection Sales and Marketing
12.4.1 Apomorphine Hydrochloride Injection Sales Channels
12.4.2 Apomorphine Hydrochloride Injection Distributors
12.5 Apomorphine Hydrochloride Injection Customers
13 Market Dynamics
13.1 Apomorphine Hydrochloride Injection Industry Trends
13.2 Apomorphine Hydrochloride Injection Market Drivers
13.3 Apomorphine Hydrochloride Injection Market Challenges
13.4 Apomorphine Hydrochloride Injection Market Restraints
14 Key Findings in The Global Apomorphine Hydrochloride Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
EVER Pharma
Evolan Pharma AB (PharmSwed)
List of Tables
    Table 1. Global Apomorphine Hydrochloride Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Pen Injectors
    Table 3. Major Manufacturers of Infusion Pumps
    Table 4. Global Apomorphine Hydrochloride Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Apomorphine Hydrochloride Injection Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Apomorphine Hydrochloride Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Apomorphine Hydrochloride Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Apomorphine Hydrochloride Injection Revenue Market Share by Region (2019-2024)
    Table 9. Global Apomorphine Hydrochloride Injection Revenue Market Share by Region (2025-2030)
    Table 10. Global Apomorphine Hydrochloride Injection Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Apomorphine Hydrochloride Injection Sales by Region (2019-2024) & (K Units)
    Table 12. Global Apomorphine Hydrochloride Injection Sales by Region (2025-2030) & (K Units)
    Table 13. Global Apomorphine Hydrochloride Injection Sales Market Share by Region (2019-2024)
    Table 14. Global Apomorphine Hydrochloride Injection Sales Market Share by Region (2025-2030)
    Table 15. Global Apomorphine Hydrochloride Injection Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Apomorphine Hydrochloride Injection Sales Share by Manufacturers (2019-2024)
    Table 17. Global Apomorphine Hydrochloride Injection Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Apomorphine Hydrochloride Injection Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Apomorphine Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Apomorphine Hydrochloride Injection Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Apomorphine Hydrochloride Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Apomorphine Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apomorphine Hydrochloride Injection as of 2023)
    Table 23. Global Key Manufacturers of Apomorphine Hydrochloride Injection, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Apomorphine Hydrochloride Injection, Product Offered and Application
    Table 25. Global Key Manufacturers of Apomorphine Hydrochloride Injection, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Apomorphine Hydrochloride Injection Sales by Type (2019-2024) & (K Units)
    Table 28. Global Apomorphine Hydrochloride Injection Sales by Type (2025-2030) & (K Units)
    Table 29. Global Apomorphine Hydrochloride Injection Sales Share by Type (2019-2024)
    Table 30. Global Apomorphine Hydrochloride Injection Sales Share by Type (2025-2030)
    Table 31. Global Apomorphine Hydrochloride Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Apomorphine Hydrochloride Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Apomorphine Hydrochloride Injection Revenue Share by Type (2019-2024)
    Table 34. Global Apomorphine Hydrochloride Injection Revenue Share by Type (2025-2030)
    Table 35. Apomorphine Hydrochloride Injection Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Apomorphine Hydrochloride Injection Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Apomorphine Hydrochloride Injection Sales by Application (2019-2024) & (K Units)
    Table 38. Global Apomorphine Hydrochloride Injection Sales by Application (2025-2030) & (K Units)
    Table 39. Global Apomorphine Hydrochloride Injection Sales Share by Application (2019-2024)
    Table 40. Global Apomorphine Hydrochloride Injection Sales Share by Application (2025-2030)
    Table 41. Global Apomorphine Hydrochloride Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Apomorphine Hydrochloride Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Apomorphine Hydrochloride Injection Revenue Share by Application (2019-2024)
    Table 44. Global Apomorphine Hydrochloride Injection Revenue Share by Application (2025-2030)
    Table 45. Apomorphine Hydrochloride Injection Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Apomorphine Hydrochloride Injection Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Apomorphine Hydrochloride Injection Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Apomorphine Hydrochloride Injection Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Apomorphine Hydrochloride Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Apomorphine Hydrochloride Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Apomorphine Hydrochloride Injection Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Apomorphine Hydrochloride Injection Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Apomorphine Hydrochloride Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Apomorphine Hydrochloride Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Apomorphine Hydrochloride Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Apomorphine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Apomorphine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Apomorphine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Apomorphine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Apomorphine Hydrochloride Injection Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Apomorphine Hydrochloride Injection Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Apomorphine Hydrochloride Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Apomorphine Hydrochloride Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Apomorphine Hydrochloride Injection Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Apomorphine Hydrochloride Injection Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Apomorphine Hydrochloride Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Apomorphine Hydrochloride Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Apomorphine Hydrochloride Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Apomorphine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Apomorphine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Apomorphine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Apomorphine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)
    Table 73. China Apomorphine Hydrochloride Injection Sales by Type (2019-2024) & (K Units)
    Table 74. China Apomorphine Hydrochloride Injection Sales by Type (2025-2030) & (K Units)
    Table 75. China Apomorphine Hydrochloride Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Apomorphine Hydrochloride Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Apomorphine Hydrochloride Injection Sales by Application (2019-2024) & (K Units)
    Table 78. China Apomorphine Hydrochloride Injection Sales by Application (2025-2030) & (K Units)
    Table 79. China Apomorphine Hydrochloride Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Apomorphine Hydrochloride Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Apomorphine Hydrochloride Injection Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Apomorphine Hydrochloride Injection Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Apomorphine Hydrochloride Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Apomorphine Hydrochloride Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Apomorphine Hydrochloride Injection Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Apomorphine Hydrochloride Injection Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Apomorphine Hydrochloride Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Apomorphine Hydrochloride Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Apomorphine Hydrochloride Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Apomorphine Hydrochloride Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Apomorphine Hydrochloride Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Apomorphine Hydrochloride Injection Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Apomorphine Hydrochloride Injection Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Country (2025-2030) & (K Units)
    Table 107. Supernus Pharmaceuticals Company Information
    Table 108. Supernus Pharmaceuticals Description and Major Businesses
    Table 109. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Supernus Pharmaceuticals Recent Developments
    Table 112. Britannia Pharmaceuticals STADA Company Information
    Table 113. Britannia Pharmaceuticals STADA Description and Major Businesses
    Table 114. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Britannia Pharmaceuticals STADA Recent Developments
    Table 117. Ever Pharma Company Information
    Table 118. Ever Pharma Description and Major Businesses
    Table 119. Ever Pharma Apomorphine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Ever Pharma Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Ever Pharma Recent Developments
    Table 122. Evolan Pharma AB (PharmSwed) Company Information
    Table 123. Evolan Pharma AB (PharmSwed) Description and Major Businesses
    Table 124. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Evolan Pharma AB (PharmSwed) Recent Developments
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Apomorphine Hydrochloride Injection Distributors List
    Table 130. Apomorphine Hydrochloride Injection Customers List
    Table 131. Apomorphine Hydrochloride Injection Market Trends
    Table 132. Apomorphine Hydrochloride Injection Market Drivers
    Table 133. Apomorphine Hydrochloride Injection Market Challenges
    Table 134. Apomorphine Hydrochloride Injection Market Restraints
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Apomorphine Hydrochloride Injection Product Picture
    Figure 2. Global Apomorphine Hydrochloride Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Apomorphine Hydrochloride Injection Market Share by Type in 2023 & 2030
    Figure 4. Pen Injectors Product Picture
    Figure 5. Infusion Pumps Product Picture
    Figure 6. Global Apomorphine Hydrochloride Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Apomorphine Hydrochloride Injection Market Share by Application in 2023 & 2030
    Figure 8. Parkinson Disease
    Figure 9. Erectile Dysfunction
    Figure 10. Apomorphine Hydrochloride Injection Report Years Considered
    Figure 11. Global Apomorphine Hydrochloride Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Apomorphine Hydrochloride Injection Revenue 2019-2030 (US$ Million)
    Figure 13. Global Apomorphine Hydrochloride Injection Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Apomorphine Hydrochloride Injection Revenue Market Share by Region (2019-2030)
    Figure 15. Global Apomorphine Hydrochloride Injection Sales 2019-2030 ((K Units)
    Figure 16. Global Apomorphine Hydrochloride Injection Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Apomorphine Hydrochloride Injection Sales YoY (2019-2030) & (K Units)
    Figure 18. US & Canada Apomorphine Hydrochloride Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Apomorphine Hydrochloride Injection Sales YoY (2019-2030) & (K Units)
    Figure 20. Europe Apomorphine Hydrochloride Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Apomorphine Hydrochloride Injection Sales YoY (2019-2030) & (K Units)
    Figure 22. China Apomorphine Hydrochloride Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Apomorphine Hydrochloride Injection Sales YoY (2019-2030) & (K Units)
    Figure 24. Asia (excluding China) Apomorphine Hydrochloride Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales YoY (2019-2030) & (K Units)
    Figure 26. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Apomorphine Hydrochloride Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Apomorphine Hydrochloride Injection in the World: Market Share by Apomorphine Hydrochloride Injection Revenue in 2023
    Figure 29. Global Apomorphine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
    Figure 31. Global Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
    Figure 32. Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
    Figure 33. Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Apomorphine Hydrochloride Injection Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Apomorphine Hydrochloride Injection Sales Share by Country (2019-2030)
    Figure 40. U.S. Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
    Figure 43. Europe Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
    Figure 45. Europe Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Apomorphine Hydrochloride Injection Revenue Share by Country (2019-2030)
    Figure 47. Europe Apomorphine Hydrochloride Injection Sales Share by Country (2019-2030)
    Figure 48. Germany Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 49. France Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 53. China Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
    Figure 54. China Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
    Figure 55. China Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
    Figure 56. China Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
    Figure 58. Asia Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
    Figure 60. Asia Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Apomorphine Hydrochloride Injection Revenue Share by Region (2019-2030)
    Figure 62. Asia Apomorphine Hydrochloride Injection Sales Share by Region (2019-2030)
    Figure 63. Japan Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 67. India Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales Share by Country (2019-2030)
    Figure 74. Brazil Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Apomorphine Hydrochloride Injection Revenue (2019-2030) & (US$ Million)
    Figure 79. Apomorphine Hydrochloride Injection Value Chain
    Figure 80. Apomorphine Hydrochloride Injection Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Apomorphine Hydrochloride Market Insights Forecast to 2030
Global Apomorphine Delivery Device Market Insights Forecast to 2030
Global Dopamine Agonists Market Research Report 2024
Global Hydromorphone Hydrochloride Injection Market Research Report 2024
Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dopamine Receptor Agonists For PD Market Research Report 2025
Global Dopamine Receptor Agonists Market Research Report 2025
Global Dopamine Hydrochloride API Market Research Report 2025
Global Tiapride Market Insights Forecast to 2030
Global Tiapride Hydrochloride Tablets Market Research Report 2024
Opioids Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lurasidone Hydrochloride API Market Research Report 2024
Hydromorphone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meperidine Hydrochloride Injection Market Research Report 2024
Global Selegiline Hydrochloride Market Research Report 2024
Global Doxapram Hydrochloride Injection Market Research Report 2024
Global Dopamine Hydrochloride Injection Market Research Report 2024
Global Portable Apomorphine Delivery Device Market Research Report 2025
Global Agomelatine Market Research Report 2024
Global Nalmefene Hydrochloride Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions